Identifai Genetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cost of Revenue	-	0.02	-
Gross Profit	-	-0.02	-
Selling, General & Admin	0.41	0.28	0.23
Research & Development	1.87	1.28	0.85
Other Operating Expenses	-	-0	-
Operating Expenses	2.29	1.56	1.08
Operating Income	-2.29	-1.58	-1.08
Interest Expense	-0.01	-0	-0
Interest & Investment Income	0.01	0.02	0.02
Currency Exchange Gain (Loss)	0.08	-	-
Other Non Operating Income (Expenses)	0.49	-	-
EBT Excluding Unusual Items	-1.72	-1.56	-1.06
Gain (Loss) on Sale of Investments	-	0	0
Pretax Income	-1.72	-1.56	-1.06
Net Income	-1.72	-1.56	-1.06
Net Income to Common	-1.72	-1.56	-1.06
Net Income Growth	-	-	-
Shares Outstanding (Basic)	1	1	1
Shares Outstanding (Diluted)	1	1	1
Shares Change	0.44%	1.82%	-
EPS (Basic)	-1.41	-1.28	-0.88
EPS (Diluted)	-1.41	-1.28	-0.88
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-2.23	-	-
Free Cash Flow Per Share	-1.82	-	-
EBITDA	-2.28	-	-
D&A For EBITDA	0.01	-	-
EBIT	-2.29	-1.58	-1.08
Advertising Expenses	0	0	0